{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:56:33Z","timestamp":1771034193661,"version":"3.50.1"},"reference-count":15,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>Alveolar echinococcosis is an emerging zoonotic disease caused by the parasite <jats:italic>Echinococcus multilocularis<\/jats:italic>. Most patients are diagnosed at a late stage, when lifelong treatment with benzimidazoles is required to stop disease progression. However, for patients who do not tolerate benzimidazole therapy, there are no alternatives. Here, we present a patient with advanced alveolar echinococcosis who was successfully treated with amphotericin B deoxycholate and mefloquine as a rescue therapy after he developed albendazole intolerance.<\/jats:p>","DOI":"10.4269\/ajtmh.22-0465","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T14:21:04Z","timestamp":1675088464000},"page":"581-583","source":"Crossref","is-referenced-by-count":8,"title":["Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis"],"prefix":"10.4269","volume":"108","author":[{"given":"Karlo","family":"Jelicic","sequence":"first","affiliation":[{"name":"University Hospital for Infectious Diseases Zagreb, Zagreb, Croatia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neven","family":"Papic","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases Zagreb, Zagreb, Croatia;"},{"name":"School of Medicine, University of Zagreb, Zagreb, Croatia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaudija","family":"Viskovic","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases Zagreb, Zagreb, Croatia;"},{"name":"Faculty of Health Studies, University of Rijeka, Rijeka, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Vince","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases Zagreb, Zagreb, Croatia;"},{"name":"School of Medicine, University of Zagreb, Zagreb, Croatia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Int J Infect Dis","first-page":"125","article-title":"Echinococcosis: A review","volume":"13","author":"Moro","year":"2009"},{"key":"b2","series-title":"Acta Trop","first-page":"1","article-title":"Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans","volume":"114","author":"Brunetti","year":"2010"},{"key":"b3","series-title":"Br J Surg","first-page":"1110","article-title":"Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis","volume":"92","author":"Kadry","year":"2005"},{"key":"b4","series-title":"Clin Microbiol Rev","first-page":"e00075-18","article-title":"Echinococcosis: Advances in the 21st century","volume":"32","author":"Wen","year":"2019"},{"key":"b5","series-title":"J Hepatol","first-page":"72","article-title":"Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years","volume":"49","author":"Torgerson","year":"2008"},{"key":"b6","series-title":"PLoS Negl Trop Dis","first-page":"e0006422","article-title":"Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets","volume":"12","author":"Siles-Lucas","year":"2018"},{"key":"b7","series-title":"Emerg Infect Dis","first-page":"364","article-title":"Human alveolar echinococcosis, Croatia","volume":"26","author":"Dusek","year":"2020"},{"key":"b8","series-title":"Parasite","first-page":"70","article-title":"Treatment of echinococcosis: Albendazole and mebendazole\u2013what else?","volume":"21","author":"Hemphill","year":"2014"},{"key":"b9","series-title":"Int J Parasitol Drugs Drug Resist","first-page":"121","article-title":"Drug repurposing applied: activity of the anti-malarial mefloquine against Echinococcus multilocularis.","volume":"13","author":"Lundstrom-Stadelmann","year":"2020"},{"key":"b10","series-title":"Antimicrob Agents Chemother","first-page":"3586","article-title":"Salvage treatment with amphotericin B in progressive human alveolar echinococcosis","volume":"47","author":"Reuter","year":"2003"},{"key":"b11","series-title":"Ann Trop Med Parasitol","first-page":"177","article-title":"Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis","volume":"103","author":"Tappe","year":"2009"},{"key":"b12","series-title":"Antimicrob Agents Chemother","first-page":"620","article-title":"Effect of amphotericin B on larval growth of Echinococcus multilocularis","volume":"47","author":"Reuter","year":"2003"},{"key":"b13","series-title":"Pathogens","first-page":"333","article-title":"Salvage therapy for alveolar echinococcosis \u2013 A case series","volume":"11","author":"Burkert","year":"2022"},{"key":"b14","series-title":"Hepatology","first-page":"509","article-title":"Structured treatment interruption in patients with alveolar echinococcosis","volume":"39","author":"Reuter","year":"2004"},{"key":"b15","series-title":"PLoS Negl Trop Dis","first-page":"e0010146","article-title":"Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study","volume":"16","author":"Deibel","year":"2022"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/108\/3\/article-p581.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/108\/3\/article-p581.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/108\/3\/article-p581.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T13:25:05Z","timestamp":1677677105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/108\/3\/article-p581.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":15,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.22-0465","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}